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↑What is “already known” in this topic: 
Epidermolysis bullosa simplex (EBS) is one of the most common genetic 
bullous skin diseases characterized by the separation of the skin at the 
basal keratinocytes region after trauma and blister formation. The most 
important and most commonly occurring molecular defects in these 
patients are the defects of keratins 5 and14 (KRT5 and KRT14).   
 
→What this article adds: 
Exons 1 and 6-7 of KRT5 and exons 1 and 4-7 of KRT14 mutation 
detection were performed in this study. The results of molecular analyzing 
showed that the most severe phenotypes were associated with mutations in 
highly conserved regions. In some cases, different inheritance modes were 
observed. These mutations showed regional variations useful in genetic 
counseling and prenatal testing in different ethnic groups. Our data 
demonstrated the heterogenic status of KRT5 and KRT14 genes mutations.  
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Abstract 
    Background: Epidermolysis bullosa simplex is a hereditary skin disorder caused by mutations in several genes such as KRT5 and 
KRT14. Skin fragility in basal keratinocytes presence regions led to the cytolysis of epidermis and blistering. Aim of this study was to 
detect the molecular defects in KRT5 and KRT14 genes hot spots in patients with clinical suspicion of EBS and investigation of their 
probable genotype-phenotype correlations. 
   Methods: Exons 1 and 6-7 of KRT5 and exons 1 and 4-7 of KRT14 amplification and mutation detection were performed by 
polymerase chain reaction and Sanger sequencing, respectively. Novel variants pathogenicity evaluated by bioinformatics tools. 
   Results: Nine important variants detected in seven different patients within 6 Iranian families affected by Epidermolysis bullosa 
simplex, of which four variants were novel. Three patients had a mottled pigmentation phenotype [G96D (p.Gly96Asp) and F97I 
(p.Phe97Ile) in KRT5]. One of them showed a Dowling–Meara phenotype [A417P (p.Ala417Pro) and E477D (p.Glu477Asp) in KRT5] 
and another had a Koebner type phenotype [R397I (p.Arg397Ile) and Q444* (p.Gln444Ter) in KRT5]. A novel variant [G92E 
(p.Gly92Glu) in KRT5] in a double heterozygous state with a challenging variant [A413T (p.Ala413Thr) in KRT14] identified in one 
patient with Koebner type phenotype. Also, a previously reported mutation [I377T (p.Ile377Thr) in KRT14 gene] identified in this 
study.  
   Conclusion: The results of molecular data analysis showed that the most severe phenotypes were associated with mutations in 
highly conserved regions. In some cases, different inheritance modes were observed. 
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Introduction 
Epidermolysis bullosa simplex (EBS) is a group of ge-
nodermatoses characterized by fragility of the skin and 
separation of tissue through basal keratinocytes that re-
sulted in intraepidermal blistering upon mild mechanical 
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trauma (1). Among all EB cases, the most common sub-
type is EBS, with an approximate prevalence of 1 in 25 
000–50 000 (2, 3). However, the prevalence of EBS in 
Iran remains unknown. Localized EBS (the mildest form), 
generalized intermediate EBS, EBS-with mottled pigmen-
tation and generalized severe EBS (Dowling-Meara type) 
are the most common subtypes of EBS (4, 5). 
The underlying mutations in EBS are mostly affected by 
KRT5 and KRT14. These genes encode keratin 5 (K5) and 
14 (K14) that typically expressed in the epidermal basal 
layer (6, 7). Keratin filaments are part of cytoskeletal in-
termediate filament proteins. Interactions between keratin 
5 and 14 filaments using their α-helical rod domains to 
bundle formation have essential roles for strength and 
flexibility to basal keratinocytes and maintenance of epi-
dermis integrity and resilience against physical traumas 
(7-10). Recessive mutations are usually reported in KRT14 
gene, while dominant mutations (especially missense mu-
tations) have been seen in both genes (11-13). In the 
Western world (with a low prevalence of consanguineous 
marriage) remarkable proportion of EBS cases have auto-
somal dominant inheritance pattern, whereas in regions or 
countries with a high prevalence of inbreeding, autosomal 
recessive inheritance is more prevalent (11, 14). Through 
analysis of phenotype-genotype correlation has been re-
vealed that mutation in highly conserved regions in kera-
tin molecule (two terminals of the central rod section) is 
usually related to a severe phenotype (generalized severe 
EBS). Mutations in less conserved areas are related to 
milder phenotypes (e.g., Localized EBS) (15-17). Moreo-
ver, the nature of the amino acid alteration affects the se-
verity of the disease (18, 19). 
In this study, we carried out the analysis of molecular 
genetics of keratin mutations in 12 families of Iranian 
patients suspected to Epidermolysis bullosa simplex to 
investigate the mode of inheritance and correlation be-
tween genotype-phenotype. At the end of this study, we 
debate how these molecular alterations create different 
phenotypic manifestations. 
 
Methods 
Patient selection: According to precise clinical exami-
nations, family history and pattern of inheritance, 15 pa-
tients in 12 families diagnosed with EBS. Criteria of diag-
nosis for patient selection and their classification were 
based on the report of the Third international consensus 
meeting on diagnosis and classification of Epidermolysis 
bullosa (20). After approval by the Medical Ethics Com-
mittee of Iran University of Medical Sciences, all patients 
and their families contributed to this study with fully in-
formed consent for sample collection and sequencing of 
DNA. Then 5 ml of blood was collected into Ethylenedia-
minetetraacetic acid tubes from patients and their relatives. 
PCR and Mutation detection: Genomic DNA was iso-
lated from peripheral blood leukocytes using the salting-
out method (21). Polymerase chain reaction (PCR) ampli-
fication of KRT5 exons 1, 6-7, KRT14 exons 1, 4-7 and 
their flanking intronic sequences performed. The sequence 
of primers used for PCR amplification of the specific am-
plicons was described previously (Table 1) (22). Each 
PCR reaction was contained 12.5 µl of PCR master mix, 
2.5 µl of genomic DNA (Approximately 100-150 ng of 
DNA), 0.4µl  of forward primer (with a concentration of 
10 pmol/ul), 0.4µl of reverse primer (with a concentration 
of 10 pmol/ul) and 9.2µl of double-distilled water. Initial 
denaturation at 94 0C for 5 min and then 30 amplification 
cycles were performed with a program contained 1 min at 
94 0C, 1 min at 60 0C and 1 min at 72 0C with a final incu-
bation of 5 min at 72 0C for all of the exons were the same 
except primers of KRT14 exon 4-7 that their annealing 
temperature was 63 0C (to avoid amplification of the 
KRT14 pseudogene). PCR Products purified and se-
quenced (using ABI 3730XL DNA Sequencer by Macro-
gen Company). For the detection of mutations, PCR prod-
uct sequences were compared with sequences obtained 
from GenBank accession number NM_000424.3  as a 
reference sequence for KRT5 and GenBank accession 
number NM_000526.3 as a reference sequence for KRT14 
(http://www.ncbi.nlm.nih.gov/).  
 
Results 
Phenotypic observations: From the 12 families, 15 af-
fected individuals were clinically evaluated (Table 2). An 
explicit EBS-DM (Dowling–Meara) phenotype in four 
probands from 4 unrelated families and an ambiguous 
phenotype in an intermediate mode between Dowling–
Meara and Koebner type in one patient (patient 5) were 
observed. Three patients from 2 unrelated families showed 
EBS with mottled pigmentation phenotype. Five patients 
from 3 different families had a Koebner type of EBS. Al-
so, 2 patients in 2 separate families showed a We-
ber‐Cockayne phenotype. The eldest and youngest pa-
tients were 48 and 4 years old, respectively. The preva-
lence of consanguineous marriages among the selected 
families was 58.3% and families were from several differ-
ent Iranian ethnic groups. Clinical features of patients 
have been shown in Figure 1. 
Keratin mutation identification: Sequence analysis of 
the KRT5 and KRT14 genes revealed 9 variants that are 
listed in Table 3 and Figure 2. Four variants have not been 
reported previously and five are known. 8 of 9 variants 
were missense and one was nonsense. Four novel variants 
with probable pathologic importance in KRT5 were 
c.289T>A in exon 1(patients 1, 2 and 15), c.1190G>T in 
exon 6 and c.1330C>T in exon 7(patient 14), c.1249G>C 
in exon 7(patient 5). Despite the previous report from two 
Table1. Primers and their sequences 
 
Gene / exon 
Primer (Sequence 5’ to 3’) 
Forward Reverse 
KRT5/e1 AGCTCTGTTCTCTCCAGCAC CAGTCTAATTCAGAACGTGTCC 
KRT5/e6-7 TCACTGCCTGTGAACTTTGG GGCCATGAGTCAGACTGAAA 
KRT14/e1 TTACCCGAGCACCTTCTCTTC TGCTGGAGAACAAGTAGCTGC 
KRT14/e4-7 GGCCTAAGGAACACCAATCC CACTAGAGCTCAGCCCCTCA 
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variants [c.287G>A and c.275G>A in exon 1 of KRT5], 
no association has been reported between EBS and these 
variants so far.  Three formerly reported mutations, also 
detected (two in exon 6 of KRT14: c.1130T>C (patient 7), 
c.1237G>A (patient 4) and c.1431G>C in exon 7 of KRT5 
(patient 5)). 
 
Discussion 
In this study, we identified 9 important variants. Among 
the identified variants, four of them were not reported 
previously (Table 3).  
In family 1 (patients 1 and 2), a mother and her son af-
fected by EBS showed mottled pigmentation phenotype 
with an autosomal dominant inheritance. Interestingly, 
Table 2. Families, patients and their features  
Family Patient Sex Age Phenotype Clinical features 
1 1 Female 52 mottled pigmentation Spontaneous blistering after a minor trauma 
Nail dystrophy (Fig. 2a) 
Reticulate skin pigmentation 
Keratoderma 
2 Male 27 
2 3 Male 7 Dowling–Meara Onset age: at birth 
Blisters in herpetiform clusters on the trunk and proximal ex-
tremities 
Nail dystrophy and then nail losing 
Mucosal involvement: esophagus 
Teeth involvement 
3 4 Male 10 Koebner type Onset age: early infancy 
Blistering after minor trauma (Fig. 2c)  
Mucosal involvement 
Teeth involvement 
Nail losing 
Hyperkeratosis of the palms and soles 
4 5 Male 48 Dowling–Meara Onset age: at birth 
Nail dystrophy (Fig. 2b) and then nail losing 
Mucosal involvement: esophagus 
Teeth involvement 
Hypopigmentation and hyperpigmentation (Fig. 2b) 
5 6 Male 36 Weber‐Cockayne Onset age: adolescence 
Blistering: typically restricted to hands and feet 
Healing of blisters with minor scarring 
6 7 Male 6 Weber‐Cockayne 
And 
Koebner type 
Onset age: early infancy 
Blistering in whole body surface that typically restricted to 
hands and feet (after a minor trauma) 
Mucosal involvement 
Nail losing (2 fingers) 
7 8 Female 8 Dowling–Meara Onset age: at birth 
Blisters in herpetiform clusters on the trunk and proximal ex-
tremities 
Nail dystrophy and then nail losing 
Mucosal involvement: esophagus 
Progressive hyperkeratosis of the palms 
8 9 Female 8 Dowling–Meara Onset age: at birth 
Blisters in herpetiform clusters on the trunk and proximal ex-
tremities 
Nail losing 
Mucosal involvement: esophagus 
Milia 
9 10 Female 12 Dowling–Meara Onset age: at birth 
Generalized blistering 
Mucosal involvement: esophagus 
Progressive hyperkeratosis of the palms 
Nail losing 
Milia 
Progressive hyperkeratosis of the soles 
10 11 Male 24 Koebner type Onset age: early infancy 
Nail dystrophy and then nail losing 
Mucosal involvement: esophagus 
Hypopigmentation and hyperpigmentation 
Hyperkeratosis of the palms and soles 
12 Male 31 
13 Male 22 
11 14 Female 41 Koebner type Onset age: early infancy  
Generalized blistering after a minor trauma 
Nail losing 
Teeth involvement 
Mucosal involvement 
Hypopigmentation and hyperpigmentation 
12 15 Female 38 mottled pigmentation Onset age: at birth 
Occasionally Skin blistering: restricted to hands and feet 
Reticulate skin pigmentation 
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4 
their clinical features (Table 2) were modified and re-
duced symptom severity over time. Two heterozygous 
variants identified in KRT5 gene were located within the 
head domain of keratin 5 protein (Fig. 2a). Since the mu-
tations in this region appeared to be consistent with mott-
led pigmentation phenotype, therefore a genotype-
phenotype correlation was observed (23). The first variant, 
which is considered as a disease-causing variant, is 
c.287G>A with G96D (p.Gly96Asp) effect. According to 
the ACMG guideline, this variant is considered as an Un-
certain Significance by getting scores PP3, PP4 (due to 
patient’s phenotype highly specific for the gene) and PM2 
(because of this variant absent in South Asian population). 
The other variant (c.289T>A with F97I (p.Phe97Ile) ef-
fect) was a novel genetic variant. According to the ACMG 
guidelines by getting score PM2, this variant is considered 
as Uncertain Significance. Patient 15 (in family 12) had 
very milder symptoms than family 1 and unexpectedly 
carried de novo c.289T>A variant. This suggests that this 
variant has a possible synergic genetic effect with 
c.287G>A variant. 
Patient 4 (in family 3) was one of the interesting cases 
in this study because of having a double heterozygous 
state for KRT5 and KRT14 genes. His clinical features 
were concordant with EBS, Koebner type. An important 
identified variant was c.1237G>A in KRT14 gene. First 
report of this variant was in a Taiwanese patient with 
EBS, Koebner type (24). However, in the study conducted 
by Ken Natsuga et al. (25), in a Japanese family, three 
normal Japanese had c.1237G>A transition (p.Ala413Thr) 
within KRT14 and they did not have any history of skin 
fragility or nail dystrophy. But what is more challenging, 
is a case report of EBS, Koebner type (generalized inter-
mediate) by Wakiguchi et al. (26), which is a double het-
erozygote patient; it is described that one of the causative 
mutations was c.1237G>A (p.Ala413Thr) in KRT14 and 
another mutation in KRT5. In the mentioned study, mother 
and sister of the patient were asymptomatic and carried 
c.1237G>A in the KRT14 gene, but no mutation in KRT5 
gene. Another important variant found in patient 4, was 
c.275G>A in KRT5 gene with G92E (p.Gly92Glu) effect. 
This variant is located in the head domain of keratin 5 
protein (Fig. 2a) and according to the ACMG guideline, 
considered as Uncertain Significance (because of two 
scores: PP3 and PM2). However, it is important to note 
that c.1237G>A in KRT14 is located in the terminal site of 
the helix2B motif (IF rod) (Fig. 2b) and is concordant with 
the phenotype of the patient. Therefore the presence of 
these two variants maybe suggested a digenic pattern of 
inheritance. 
An unequivocal Koebner type phenotype was observed 
in patient 14(in family 11). Mutation analysis revealed 
two novel variants in KRT5 gene in a compound heterozy-
gous state and an autosomal recessive inheritance in this 
patient. Both of these variants are located in the helix 2B 
motif (IF rod domain) of keratin5 protein (Fig. 2a) that is 
concordant with the patient's phenotype (genotype-
phenotype correlation). The first variant is a nonsense 
variant (c.1330C>T) in exon 7 of KRT5 with Q444* 
(p.Gln444Ter) effect. c.1330C>T in KRT5 by getting 
 
Fig.1. Some clinical features of patients. a: toe nail dystrophy in patient 1; b: nail dystrophy and then nail losing, 
Hypopigmentation and hyperpigmentation in patient 5; c: blistering scar in the sole of the foot in patient 4. 
 
Table 3. All variants found in the KRT5 and KRT14 genes in this study 
Patient Effect on coding sequence HGVS coding HGVS Protein level 
KRT5 
 1 and 2 Missense c.287G>A G96D 
1,2 and 15 Missense c.289T>A (N) F97I 
4 Missense c.275G>A G92E 
14 Missense c.1190G>T (N) R397I 
14 Nonsense c.1330C>T (N) Q444* 
5 Missense c.1249G>C (N) A417P 
5 Missense c.1431G>C E477D 
KRT14 
7 Missense c.1130T>C I377T 
4 Missense c.1237G>A A413T 
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5 
PM1, PM2, PP3 and PVS1 ACMG scores classified as a 
Pathogenic variant. Another novel variant is c.1190G>T 
(p.Arg397Ile) in exon 6 of KRT5. ACMG scores for this 
variant are PM1, PM2, and PP3 that fall into the Uncertain 
Significance category.  
An unclear intermediate phenotype between Dowling–
Meara and Koebner type was characterized by a probable 
autosomal recessive inheritance that was observed in pa-
tient 5. This patient was compound heterozygous for both 
variants c.1249G>C and c.1431G>C in KRT5 gene. Both 
were located at the helix 2B motif (IF rod domain) of ker-
atin 5 protein (Fig. 2a) and they were correlated with 
Dowling–Meara patient's phenotype. c.1249G>C was a 
novel variant (being PM1, PM2 and PP3) and considered 
as an Uncertain Significance. c.1431G>C transition in 
KRT5 (E477D (p.Glu477Asp)) in a heterozygous state 
was previously reported in a patient with EB simplex 
Dowling–Meara accompanied by verrucous carcinoma 
(27). However, a study by Homberg M et al. (28), sug-
gested that E477D in Keratin 5 for causing severe general-
ized EBS requires genetic modifiers. The probable genetic 
modifier for this phenotype in patient 5 can be 1249G>C 
variant. 
The c.1130T>C transition in exon 6 of KRT14 gene 
(I377T (p.Ile377Thr)) was found in a homozygous state in 
patient 7(in family 6). This mutation was first previously 
reported by Rugg EL et al. (29) in a patient with localized 
EBS (Weber‐Cockayne) and subsequently, in 2016, it was 
described by Vahidnezhad H et al. (30) in a large Iranian 
family with a high degree of consanguineous marriage. 
According to their observations, semi-dominant inher-
itance was suggested for this genetic alteration and its 
impacts (30). However, in this study, the patient's clinical 
features (Table 2) were severe while his mother and father 
were asymptomatic (only have minor blisters in the sole of 
the foot after a long walking). Therefore, it was difficult to 
determine the inheritance pattern. However, it appears that 
the homozygous state caused Koebner type; and the heter-
ozygous state developed Weber‐Cockayne. 
In this study, 15 EBS patients were screened for se-
quence variation in exons 1, 6-7 of KRT5 and exons 1, 4-7 
of KRT14. Seven of them were described at the molecular 
level. Patients with no variation in mentioned exons might 
have mutations in other exons of KRT5 and KRT14 or 
other genes with overlapping phenotypes such as 
PLEC,COL17A1 and ITGB4 (23, 31). Moreover, para 
mutations as epigenetic phenomena may also be involved 
in the pathogenesis of EBS (32).  
 
Conclusion 
We found 9 important variants in KRT5 and KRT14 
genes. According to Our data, for rapid mutation screen-
 
Fig. 2. Schematic picture from variants in KRT5 and KRT14 genes. a: KRT5 exons and protein; b: KRT14 exons and protein 
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6 
ing of EBS, we recommend mutation analysis of the 
hotspots of these genes. Genotype-phenotype correlation 
can be useful for the interpretation of molecular variants. 
Finally, next generation sequencing can be an alternative 
method for mutation detection and copy number variation 
analysis in patients with EBS. 
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